China’s Export Dominance: What to Know
Posted inBanking and Financial Institutions BYD Co Ltd China Customs (Tariff) Electric and Hybrid Vehicles Europe Factories and Manufacturing Foreign Investments International Relations International Trade and World Market Solar Energy Supply Chain United States

China’s Export Dominance: What to Know

From cars to solar panels to furniture, China is using lavish bank lending and enormous investments in robotics to cement its global leadership in manufacturing.
Trains, Trucks and Tractors: The Race to Reroute Goods From Baltimore
Posted inBaltimore (Md) Bridges and Tunnels Brunswick (Ga) Coal Containers and Packaging Cotton, Rick East Coast (US) Freight (Cargo) Georgia Ports Authority International Longshoremen's Assn International Trade and World Market Labor and Jobs Newark (NJ) Norfolk (Va) Norfolk Southern Corporation Port Authority of New York and New Jersey Port of New York and New Jersey Ports Railroads Riggs Amico, Sarah Ships and Shipping Supply Chain Trucks and Trucking United States Economy

Trains, Trucks and Tractors: The Race to Reroute Goods From Baltimore

Since the collapse of the Key Bridge, other East Coast ports have absorbed the cargo previously handled in Baltimore, but some parts of the supply chain like trucking are struggling.
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.